Starpharma Holdings Limited · ASX:SPL

Starpharma Holdings Limited financial statements

Starpharma Holdings Limited's income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in AUD

Income statement

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue12.1M4.91M8.29M2.94M4.68M1.80M6.03M2.72M4.96M3.65M
Cost of revenue1.66M1.22M632.0K1.72M2.78M1.26M1.80M251.0K00
Gross profit10.4M3.69M7.66M1.22M1.91M539.5K4.23M2.47M4.96M3.65M
Research and development22.3M8.36M15.6M18.9M18.9M22.3M20.5M15.5M14.6M18.1M
Selling, general and administrative3.20M3.03M3.57M3.77M3.29M4.02M2.67M2.50M2.24M2.94M
Operating income-19.2M-12.0M-15.2M-24.7M-23.9M-28.7M-21.4M-14.3M-10.3M-15.2M
Depreciation and amortization911.0K1.07M1.11M1.19M1.08M935.0K911.0K298.0K311.0K318.0K
EBITDA-18.3M-10.9M-14.0M-23.5M-22.8M-27.7M-20.5M-14.0M-9.97M-14.9M
Interest expense217.0K00001.00K
Income before tax-18.6M-9.99M-13.7M-23.3M-23.4M-27.0M-20.3M-14.3M-10.3M-15.2M
Income tax-11.1M-8.36M-5.53M-7.63M-7.26M-7.25M-5.67M-5.07M-4.06M-3.25M
Net income-7.46M-9.99M-8.16M-15.6M-16.2M-19.7M-14.7M-14.3M-10.3M-15.2M
Earnings per share, basic-0.02-0.02-0.02-0.04-0.04-0.05-0.04-0.04-0.03-0.04

Balance sheet

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash and equivalents11.0M15.4M23.4M35.2M49.9M60.5M30.1M41.3M51.3M61.2M
Short-term investments0
Receivables4.39M4.22M6.34M8.23M7.84M8.44M6.09M959.0K5.91M3.84M
Inventory1.66M1.92M2.41M2.77M2.82M1.72M494.0K399.0K1
Current assets17.6M22.6M32.9M47.1M60.7M70.8M36.7M47.8M57.5M65.7M
Property, plant and equipment2.86M3.90M4.96M5.52M2.48M2.40M1.05M1.06M913.0K
Goodwill0
Total assets19.0M25.4M36.8M52.1M66.2M73.2M39.1M48.9M58.5M66.6M
Accounts payable2.14M2.05M2.73M6.62M6.76M6.71M4.39M4.10M3.02M4.03M
Current liabilities5.17M5.23M6.66M14.5M10.2M10.4M6.70M6.43M5.16M5.52M
Long-term debt04.00M23.0K47.0K
Total debt707.0K2.40M3.53M8.27M8.19M1.17M1.57M26.0K49.0K70.0K
Total liabilities5.24M6.42M8.70M17.3M17.8M10.9M7.75M6.46M5.23M5.61M
Shareholders' equity13.8M19.0M28.1M34.8M48.4M62.3M31.3M42.4M53.3M61.0M
Shares outstanding430.8M417.2M411.4M409.0M406.9M396.9M372.2M371.3M370.1M368.2M

Cash flow

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations-3.21M-6.76M-6.98M-13.5M-13.2M-14.8M-10.8M-10.3M-10.2M-17.0M
Capital spending-287.0K-42.0K-89.0K-621.0K-837.0K-246.0K-125.0K-314.0K-359.0K-625.0K
Free cash flow-3.50M-6.80M-7.07M-14.2M-14.0M-15.1M-10.9M-10.7M-10.6M-17.6M
Cash from investing-259.0K-42.0K-89.0K-610.0K-836.0K-246.0K-125.0K-306.0K-359.0K32.7M
Cash from financing-876.0K-1.13M-4.75M-695.0K3.23M46.3M-584.0K-26.0K-26.0K-21.0K
Dividends paid-46.3M0
Share buybacks0-1.93M-1.93M0
Change in cash-4.39M-7.95M-11.8M-14.7M-10.6M30.4M-11.2M-10.1M-9.87M15.2M